Koppel Adam Insider Trades

Insider Trading History

Track insider trading activity for Koppel Adam. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
10% owner
Holding Value $470k 10,461 shares
Last Trade
Aug 01, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.96B 65,683,063 shares
$45.00
$44.96
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.3k 16,000 shares
$5.52
$4.14
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
10% owner
Holding Value $618k 13,743 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$428k 10,461 shares
$40.91
$44.96
Solid Biosciences
Solid Biosciences SLDB
10% owner
Holding Value $35.5M 4,034,582 shares
Last Trade
Jan 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.96M 904,160 shares
$7.70
$8.79
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
10% owner
Holding Value $2.95B 65,679,781 shares
Last Trade
Oct 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$125M 5,480,052 shares
$22.81
$44.96
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 16,000 shares
$8.70
$4.14
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
10% owner
Holding Value $2.71B 60,199,729 shares
Last Trade
Jun 07, 2023 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$14.1M 432,627 shares
$32.60
$44.96
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
10% owner
Holding Value $620k 13,780 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$449k 13,780 shares
$32.60
$44.96
Solid Biosciences
Solid Biosciences SLDB
10% owner
Holding Value $84.8k 9,650 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.5k 9,650 shares
$6.37
$8.79
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $84.8k 9,650 shares
Last Trade
Dec 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 9,650 shares
$6.47
$8.79
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $23.4k 2,666 shares
Last Trade
Dec 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18k 2,666 shares
$6.77
$8.79
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 16,000 shares
$13.81
$4.14
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
Director
Holding Value $1.05M 23,459 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$571k 23,459 shares
$24.35
$44.96
Aptinyx
Aptinyx APTX
Director
Holding Value $3.84k 40,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20k 40,000 shares
$0.50
$0.10
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.53M 40,000 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Director
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$118M 3,080,237 shares
$38.25
$38.22
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $51.9k 12,530 shares
Last Trade
Jul 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 12,530 shares
$9.40
$4.14
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $264k 30,000 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.77M 30,000 shares
$59.10
$8.79
CEREVEL THERAPEUTC HOLDN EQY WARRANT
CEREVEL THERAPEUTC HOLDN EQY WARRANT CEREW
10% owner
Holding Value $776k 42,950 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 42,950 shares
$4.54
$18.06
Cerevel Therapeutics Holdings
Cerevel Therapeutics Holdings CERE
10% owner
Holding Value $1.93M 42,950 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$598k 42,950 shares
$13.93
$44.96

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up